Medical Devices & Consumables
Global Multiplex Sepsis Biomarker Panel Market Research Report 2025
- Dec 02, 25
- ID: 633541
- Pages: 74
- Figures: 73
- Views: 12
This report aims to provide a comprehensive presentation of the global market for Multiplex Sepsis Biomarker Panel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Sepsis Biomarker Panel.
The Multiplex Sepsis Biomarker Panel market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiplex Sepsis Biomarker Panel market comprehensively. Regional market sizes, concerning products by Type, by Application, by Diagnostic Fields and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplex Sepsis Biomarker Panel companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Atila Biosystems
EDX Medical
Seegene Inc
BIOMÉRIEUX
GCC Biotech INDIA
Labmix24
Assay Genie Ltd
T2 Biosystems
Immunexpress
Merck
Segment by Type
Multiplex Immunoassay
Microfluidics-Based Panels
Multiplex Molecular Panels
Other
Segment by Diagnostic Fields
Sepsis Diagnosis
Sepsis Prognosis
Other
Segment by Clinical Application Scenarios
ED Rapid Triage
ICU Monitoring
Antimicrobial Stewardship
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Diagnostic Fields etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Sepsis Biomarker Panel company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Multiplex Sepsis Biomarker Panel market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiplex Sepsis Biomarker Panel market comprehensively. Regional market sizes, concerning products by Type, by Application, by Diagnostic Fields and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplex Sepsis Biomarker Panel companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Atila Biosystems
EDX Medical
Seegene Inc
BIOMÉRIEUX
GCC Biotech INDIA
Labmix24
Assay Genie Ltd
T2 Biosystems
Immunexpress
Merck
Segment by Type
Multiplex Immunoassay
Microfluidics-Based Panels
Multiplex Molecular Panels
Other
Segment by Diagnostic Fields
Sepsis Diagnosis
Sepsis Prognosis
Other
Segment by Clinical Application Scenarios
ED Rapid Triage
ICU Monitoring
Antimicrobial Stewardship
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Diagnostic Fields etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Sepsis Biomarker Panel company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Multiplex Immunoassay
1.2.3 Microfluidics-Based Panels
1.2.4 Multiplex Molecular Panels
1.2.5 Other
1.3 Market by Diagnostic Fields
1.3.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Diagnostic Fields: 2020 VS 2024 VS 2031
1.3.2 Sepsis Diagnosis
1.3.3 Sepsis Prognosis
1.3.4 Other
1.4 Market by Clinical Application Scenarios
1.4.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Clinical Application Scenarios: 2020 VS 2024 VS 2031
1.4.2 ED Rapid Triage
1.4.3 ICU Monitoring
1.4.4 Antimicrobial Stewardship
1.4.5 Other
1.5 Market by Application
1.5.1 Global Multiplex Sepsis Biomarker Panel Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Sepsis Biomarker Panel Market Perspective (2020-2031)
2.2 Global Multiplex Sepsis Biomarker Panel Growth Trends by Region
2.2.1 Global Multiplex Sepsis Biomarker Panel Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multiplex Sepsis Biomarker Panel Historic Market Size by Region (2020-2025)
2.2.3 Multiplex Sepsis Biomarker Panel Forecasted Market Size by Region (2026-2031)
2.3 Multiplex Sepsis Biomarker Panel Market Dynamics
2.3.1 Multiplex Sepsis Biomarker Panel Industry Trends
2.3.2 Multiplex Sepsis Biomarker Panel Market Drivers
2.3.3 Multiplex Sepsis Biomarker Panel Market Challenges
2.3.4 Multiplex Sepsis Biomarker Panel Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex Sepsis Biomarker Panel Players by Revenue
3.1.1 Global Top Multiplex Sepsis Biomarker Panel Players by Revenue (2020-2025)
3.1.2 Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Players (2020-2025)
3.2 Global Top Multiplex Sepsis Biomarker Panel Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multiplex Sepsis Biomarker Panel Revenue
3.4 Global Multiplex Sepsis Biomarker Panel Market Concentration Ratio
3.4.1 Global Multiplex Sepsis Biomarker Panel Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Sepsis Biomarker Panel Revenue in 2024
3.5 Global Key Players of Multiplex Sepsis Biomarker Panel Head office and Area Served
3.6 Global Key Players of Multiplex Sepsis Biomarker Panel, Product and Application
3.7 Global Key Players of Multiplex Sepsis Biomarker Panel, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Sepsis Biomarker Panel Breakdown Data by Type
4.1 Global Multiplex Sepsis Biomarker Panel Historic Market Size by Type (2020-2025)
4.2 Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Type (2026-2031)
5 Multiplex Sepsis Biomarker Panel Breakdown Data by Application
5.1 Global Multiplex Sepsis Biomarker Panel Historic Market Size by Application (2020-2025)
5.2 Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
6.2 North America Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
6.4 North America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
7.2 Europe Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
7.4 Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
8.2 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025)
8.4 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
9.2 Latin America Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
9.4 Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
10.2 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
10.4 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Atila Biosystems
11.1.1 Atila Biosystems Company Details
11.1.2 Atila Biosystems Business Overview
11.1.3 Atila Biosystems Multiplex Sepsis Biomarker Panel Introduction
11.1.4 Atila Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.1.5 Atila Biosystems Recent Development
11.2 EDX Medical
11.2.1 EDX Medical Company Details
11.2.2 EDX Medical Business Overview
11.2.3 EDX Medical Multiplex Sepsis Biomarker Panel Introduction
11.2.4 EDX Medical Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.2.5 EDX Medical Recent Development
11.3 Seegene Inc
11.3.1 Seegene Inc Company Details
11.3.2 Seegene Inc Business Overview
11.3.3 Seegene Inc Multiplex Sepsis Biomarker Panel Introduction
11.3.4 Seegene Inc Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.3.5 Seegene Inc Recent Development
11.4 BIOMÉRIEUX
11.4.1 BIOMÉRIEUX Company Details
11.4.2 BIOMÉRIEUX Business Overview
11.4.3 BIOMÉRIEUX Multiplex Sepsis Biomarker Panel Introduction
11.4.4 BIOMÉRIEUX Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.4.5 BIOMÉRIEUX Recent Development
11.5 GCC Biotech INDIA
11.5.1 GCC Biotech INDIA Company Details
11.5.2 GCC Biotech INDIA Business Overview
11.5.3 GCC Biotech INDIA Multiplex Sepsis Biomarker Panel Introduction
11.5.4 GCC Biotech INDIA Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.5.5 GCC Biotech INDIA Recent Development
11.6 Labmix24
11.6.1 Labmix24 Company Details
11.6.2 Labmix24 Business Overview
11.6.3 Labmix24 Multiplex Sepsis Biomarker Panel Introduction
11.6.4 Labmix24 Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.6.5 Labmix24 Recent Development
11.7 Assay Genie Ltd
11.7.1 Assay Genie Ltd Company Details
11.7.2 Assay Genie Ltd Business Overview
11.7.3 Assay Genie Ltd Multiplex Sepsis Biomarker Panel Introduction
11.7.4 Assay Genie Ltd Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.7.5 Assay Genie Ltd Recent Development
11.8 T2 Biosystems
11.8.1 T2 Biosystems Company Details
11.8.2 T2 Biosystems Business Overview
11.8.3 T2 Biosystems Multiplex Sepsis Biomarker Panel Introduction
11.8.4 T2 Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.8.5 T2 Biosystems Recent Development
11.9 Immunexpress
11.9.1 Immunexpress Company Details
11.9.2 Immunexpress Business Overview
11.9.3 Immunexpress Multiplex Sepsis Biomarker Panel Introduction
11.9.4 Immunexpress Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.9.5 Immunexpress Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Multiplex Sepsis Biomarker Panel Introduction
11.10.4 Merck Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Multiplex Immunoassay
1.2.3 Microfluidics-Based Panels
1.2.4 Multiplex Molecular Panels
1.2.5 Other
1.3 Market by Diagnostic Fields
1.3.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Diagnostic Fields: 2020 VS 2024 VS 2031
1.3.2 Sepsis Diagnosis
1.3.3 Sepsis Prognosis
1.3.4 Other
1.4 Market by Clinical Application Scenarios
1.4.1 Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Clinical Application Scenarios: 2020 VS 2024 VS 2031
1.4.2 ED Rapid Triage
1.4.3 ICU Monitoring
1.4.4 Antimicrobial Stewardship
1.4.5 Other
1.5 Market by Application
1.5.1 Global Multiplex Sepsis Biomarker Panel Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Sepsis Biomarker Panel Market Perspective (2020-2031)
2.2 Global Multiplex Sepsis Biomarker Panel Growth Trends by Region
2.2.1 Global Multiplex Sepsis Biomarker Panel Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multiplex Sepsis Biomarker Panel Historic Market Size by Region (2020-2025)
2.2.3 Multiplex Sepsis Biomarker Panel Forecasted Market Size by Region (2026-2031)
2.3 Multiplex Sepsis Biomarker Panel Market Dynamics
2.3.1 Multiplex Sepsis Biomarker Panel Industry Trends
2.3.2 Multiplex Sepsis Biomarker Panel Market Drivers
2.3.3 Multiplex Sepsis Biomarker Panel Market Challenges
2.3.4 Multiplex Sepsis Biomarker Panel Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex Sepsis Biomarker Panel Players by Revenue
3.1.1 Global Top Multiplex Sepsis Biomarker Panel Players by Revenue (2020-2025)
3.1.2 Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Players (2020-2025)
3.2 Global Top Multiplex Sepsis Biomarker Panel Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multiplex Sepsis Biomarker Panel Revenue
3.4 Global Multiplex Sepsis Biomarker Panel Market Concentration Ratio
3.4.1 Global Multiplex Sepsis Biomarker Panel Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Sepsis Biomarker Panel Revenue in 2024
3.5 Global Key Players of Multiplex Sepsis Biomarker Panel Head office and Area Served
3.6 Global Key Players of Multiplex Sepsis Biomarker Panel, Product and Application
3.7 Global Key Players of Multiplex Sepsis Biomarker Panel, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Sepsis Biomarker Panel Breakdown Data by Type
4.1 Global Multiplex Sepsis Biomarker Panel Historic Market Size by Type (2020-2025)
4.2 Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Type (2026-2031)
5 Multiplex Sepsis Biomarker Panel Breakdown Data by Application
5.1 Global Multiplex Sepsis Biomarker Panel Historic Market Size by Application (2020-2025)
5.2 Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
6.2 North America Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
6.4 North America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
7.2 Europe Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
7.4 Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
8.2 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025)
8.4 Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
9.2 Latin America Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
9.4 Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size (2020-2031)
10.2 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025)
10.4 Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Atila Biosystems
11.1.1 Atila Biosystems Company Details
11.1.2 Atila Biosystems Business Overview
11.1.3 Atila Biosystems Multiplex Sepsis Biomarker Panel Introduction
11.1.4 Atila Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.1.5 Atila Biosystems Recent Development
11.2 EDX Medical
11.2.1 EDX Medical Company Details
11.2.2 EDX Medical Business Overview
11.2.3 EDX Medical Multiplex Sepsis Biomarker Panel Introduction
11.2.4 EDX Medical Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.2.5 EDX Medical Recent Development
11.3 Seegene Inc
11.3.1 Seegene Inc Company Details
11.3.2 Seegene Inc Business Overview
11.3.3 Seegene Inc Multiplex Sepsis Biomarker Panel Introduction
11.3.4 Seegene Inc Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.3.5 Seegene Inc Recent Development
11.4 BIOMÉRIEUX
11.4.1 BIOMÉRIEUX Company Details
11.4.2 BIOMÉRIEUX Business Overview
11.4.3 BIOMÉRIEUX Multiplex Sepsis Biomarker Panel Introduction
11.4.4 BIOMÉRIEUX Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.4.5 BIOMÉRIEUX Recent Development
11.5 GCC Biotech INDIA
11.5.1 GCC Biotech INDIA Company Details
11.5.2 GCC Biotech INDIA Business Overview
11.5.3 GCC Biotech INDIA Multiplex Sepsis Biomarker Panel Introduction
11.5.4 GCC Biotech INDIA Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.5.5 GCC Biotech INDIA Recent Development
11.6 Labmix24
11.6.1 Labmix24 Company Details
11.6.2 Labmix24 Business Overview
11.6.3 Labmix24 Multiplex Sepsis Biomarker Panel Introduction
11.6.4 Labmix24 Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.6.5 Labmix24 Recent Development
11.7 Assay Genie Ltd
11.7.1 Assay Genie Ltd Company Details
11.7.2 Assay Genie Ltd Business Overview
11.7.3 Assay Genie Ltd Multiplex Sepsis Biomarker Panel Introduction
11.7.4 Assay Genie Ltd Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.7.5 Assay Genie Ltd Recent Development
11.8 T2 Biosystems
11.8.1 T2 Biosystems Company Details
11.8.2 T2 Biosystems Business Overview
11.8.3 T2 Biosystems Multiplex Sepsis Biomarker Panel Introduction
11.8.4 T2 Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.8.5 T2 Biosystems Recent Development
11.9 Immunexpress
11.9.1 Immunexpress Company Details
11.9.2 Immunexpress Business Overview
11.9.3 Immunexpress Multiplex Sepsis Biomarker Panel Introduction
11.9.4 Immunexpress Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.9.5 Immunexpress Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Multiplex Sepsis Biomarker Panel Introduction
11.10.4 Merck Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025)
11.10.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Multiplex Immunoassay
Table 3. Key Players of Microfluidics-Based Panels
Table 4. Key Players of Multiplex Molecular Panels
Table 5. Key Players of Other
Table 6. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Diagnostic Fields (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Sepsis Diagnosis
Table 8. Key Players of Sepsis Prognosis
Table 9. Key Players of Other
Table 10. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Clinical Application Scenarios (US$ Million): 2020 VS 2024 VS 2031
Table 11. Key Players of ED Rapid Triage
Table 12. Key Players of ICU Monitoring
Table 13. Key Players of Antimicrobial Stewardship
Table 14. Key Players of Other
Table 15. Global Multiplex Sepsis Biomarker Panel Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Multiplex Sepsis Biomarker Panel Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025) & (US$ Million)
Table 18. Global Multiplex Sepsis Biomarker Panel Market Share by Region (2020-2025)
Table 19. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 20. Global Multiplex Sepsis Biomarker Panel Market Share by Region (2026-2031)
Table 21. Multiplex Sepsis Biomarker Panel Market Trends
Table 22. Multiplex Sepsis Biomarker Panel Market Drivers
Table 23. Multiplex Sepsis Biomarker Panel Market Challenges
Table 24. Multiplex Sepsis Biomarker Panel Market Restraints
Table 25. Global Multiplex Sepsis Biomarker Panel Revenue by Players (2020-2025) & (US$ Million)
Table 26. Global Multiplex Sepsis Biomarker Panel Market Share by Players (2020-2025)
Table 27. Global Top Multiplex Sepsis Biomarker Panel Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Sepsis Biomarker Panel as of 2024)
Table 28. Ranking of Global Top Multiplex Sepsis Biomarker Panel Companies by Revenue (US$ Million) in 2024
Table 29. Global 5 Largest Players Market Share by Multiplex Sepsis Biomarker Panel Revenue (CR5 and HHI) & (2020-2025)
Table 30. Global Key Players of Multiplex Sepsis Biomarker Panel, Headquarters and Area Served
Table 31. Global Key Players of Multiplex Sepsis Biomarker Panel, Product and Application
Table 32. Global Key Players of Multiplex Sepsis Biomarker Panel, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Multiplex Sepsis Biomarker Panel Market Size by Type (2020-2025) & (US$ Million)
Table 35. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Type (2020-2025)
Table 36. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 37. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Type (2026-2031)
Table 38. Global Multiplex Sepsis Biomarker Panel Market Size by Application (2020-2025) & (US$ Million)
Table 39. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Application (2020-2025)
Table 40. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 41. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Application (2026-2031)
Table 42. North America Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. North America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 44. North America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 45. Europe Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 47. Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 48. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 49. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025) & (US$ Million)
Table 50. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2026-2031) & (US$ Million)
Table 51. Latin America Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 53. Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 54. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 55. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 56. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 57. Atila Biosystems Company Details
Table 58. Atila Biosystems Business Overview
Table 59. Atila Biosystems Multiplex Sepsis Biomarker Panel Product
Table 60. Atila Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 61. Atila Biosystems Recent Development
Table 62. EDX Medical Company Details
Table 63. EDX Medical Business Overview
Table 64. EDX Medical Multiplex Sepsis Biomarker Panel Product
Table 65. EDX Medical Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 66. EDX Medical Recent Development
Table 67. Seegene Inc Company Details
Table 68. Seegene Inc Business Overview
Table 69. Seegene Inc Multiplex Sepsis Biomarker Panel Product
Table 70. Seegene Inc Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 71. Seegene Inc Recent Development
Table 72. BIOMÉRIEUX Company Details
Table 73. BIOMÉRIEUX Business Overview
Table 74. BIOMÉRIEUX Multiplex Sepsis Biomarker Panel Product
Table 75. BIOMÉRIEUX Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 76. BIOMÉRIEUX Recent Development
Table 77. GCC Biotech INDIA Company Details
Table 78. GCC Biotech INDIA Business Overview
Table 79. GCC Biotech INDIA Multiplex Sepsis Biomarker Panel Product
Table 80. GCC Biotech INDIA Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 81. GCC Biotech INDIA Recent Development
Table 82. Labmix24 Company Details
Table 83. Labmix24 Business Overview
Table 84. Labmix24 Multiplex Sepsis Biomarker Panel Product
Table 85. Labmix24 Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 86. Labmix24 Recent Development
Table 87. Assay Genie Ltd Company Details
Table 88. Assay Genie Ltd Business Overview
Table 89. Assay Genie Ltd Multiplex Sepsis Biomarker Panel Product
Table 90. Assay Genie Ltd Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 91. Assay Genie Ltd Recent Development
Table 92. T2 Biosystems Company Details
Table 93. T2 Biosystems Business Overview
Table 94. T2 Biosystems Multiplex Sepsis Biomarker Panel Product
Table 95. T2 Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 96. T2 Biosystems Recent Development
Table 97. Immunexpress Company Details
Table 98. Immunexpress Business Overview
Table 99. Immunexpress Multiplex Sepsis Biomarker Panel Product
Table 100. Immunexpress Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 101. Immunexpress Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Multiplex Sepsis Biomarker Panel Product
Table 105. Merck Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Multiplex Sepsis Biomarker Panel Picture
Figure 2. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Multiplex Sepsis Biomarker Panel Market Share by Type: 2024 VS 2031
Figure 4. Multiplex Immunoassay Features
Figure 5. Microfluidics-Based Panels Features
Figure 6. Multiplex Molecular Panels Features
Figure 7. Other Features
Figure 8. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Diagnostic Fields (2020-2031) & (US$ Million)
Figure 9. Sepsis Diagnosis Features
Figure 10. Sepsis Prognosis Features
Figure 11. Other Features
Figure 12. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Clinical Application Scenarios (2020-2031) & (US$ Million)
Figure 13. ED Rapid Triage Features
Figure 14. ICU Monitoring Features
Figure 15. Antimicrobial Stewardship Features
Figure 16. Other Features
Figure 17. Global Multiplex Sepsis Biomarker Panel Market Size by Application (2020-2031) & (US$ Million)
Figure 18. Global Multiplex Sepsis Biomarker Panel Market Share by Application: 2024 VS 2031
Figure 19. Hospital Case Studies
Figure 20. Clinic Case Studies
Figure 21. Other Case Studies
Figure 22. Multiplex Sepsis Biomarker Panel Report Years Considered
Figure 23. Global Multiplex Sepsis Biomarker Panel Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global Multiplex Sepsis Biomarker Panel Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Multiplex Sepsis Biomarker Panel Market Share by Region: 2024 VS 2031
Figure 26. Global Multiplex Sepsis Biomarker Panel Market Share by Players in 2024
Figure 27. Global Multiplex Sepsis Biomarker Panel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Multiplex Sepsis Biomarker Panel Revenue in 2024
Figure 29. North America Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 31. United States Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 35. Germany Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Share by Region (2020-2031)
Figure 43. China Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 51. Mexico Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 55. Israel Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Atila Biosystems Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 59. EDX Medical Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 60. Seegene Inc Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 61. BIOMÉRIEUX Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 62. GCC Biotech INDIA Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 63. Labmix24 Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 64. Assay Genie Ltd Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 65. T2 Biosystems Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 66. Immunexpress Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 67. Merck Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Multiplex Immunoassay
Table 3. Key Players of Microfluidics-Based Panels
Table 4. Key Players of Multiplex Molecular Panels
Table 5. Key Players of Other
Table 6. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Diagnostic Fields (US$ Million): 2020 VS 2024 VS 2031
Table 7. Key Players of Sepsis Diagnosis
Table 8. Key Players of Sepsis Prognosis
Table 9. Key Players of Other
Table 10. Global Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Clinical Application Scenarios (US$ Million): 2020 VS 2024 VS 2031
Table 11. Key Players of ED Rapid Triage
Table 12. Key Players of ICU Monitoring
Table 13. Key Players of Antimicrobial Stewardship
Table 14. Key Players of Other
Table 15. Global Multiplex Sepsis Biomarker Panel Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Multiplex Sepsis Biomarker Panel Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025) & (US$ Million)
Table 18. Global Multiplex Sepsis Biomarker Panel Market Share by Region (2020-2025)
Table 19. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 20. Global Multiplex Sepsis Biomarker Panel Market Share by Region (2026-2031)
Table 21. Multiplex Sepsis Biomarker Panel Market Trends
Table 22. Multiplex Sepsis Biomarker Panel Market Drivers
Table 23. Multiplex Sepsis Biomarker Panel Market Challenges
Table 24. Multiplex Sepsis Biomarker Panel Market Restraints
Table 25. Global Multiplex Sepsis Biomarker Panel Revenue by Players (2020-2025) & (US$ Million)
Table 26. Global Multiplex Sepsis Biomarker Panel Market Share by Players (2020-2025)
Table 27. Global Top Multiplex Sepsis Biomarker Panel Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiplex Sepsis Biomarker Panel as of 2024)
Table 28. Ranking of Global Top Multiplex Sepsis Biomarker Panel Companies by Revenue (US$ Million) in 2024
Table 29. Global 5 Largest Players Market Share by Multiplex Sepsis Biomarker Panel Revenue (CR5 and HHI) & (2020-2025)
Table 30. Global Key Players of Multiplex Sepsis Biomarker Panel, Headquarters and Area Served
Table 31. Global Key Players of Multiplex Sepsis Biomarker Panel, Product and Application
Table 32. Global Key Players of Multiplex Sepsis Biomarker Panel, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Multiplex Sepsis Biomarker Panel Market Size by Type (2020-2025) & (US$ Million)
Table 35. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Type (2020-2025)
Table 36. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 37. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Type (2026-2031)
Table 38. Global Multiplex Sepsis Biomarker Panel Market Size by Application (2020-2025) & (US$ Million)
Table 39. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Application (2020-2025)
Table 40. Global Multiplex Sepsis Biomarker Panel Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 41. Global Multiplex Sepsis Biomarker Panel Revenue Market Share by Application (2026-2031)
Table 42. North America Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. North America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 44. North America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 45. Europe Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 47. Europe Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 48. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 49. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2020-2025) & (US$ Million)
Table 50. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size by Region (2026-2031) & (US$ Million)
Table 51. Latin America Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 52. Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 53. Latin America Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 54. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 55. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2020-2025) & (US$ Million)
Table 56. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size by Country (2026-2031) & (US$ Million)
Table 57. Atila Biosystems Company Details
Table 58. Atila Biosystems Business Overview
Table 59. Atila Biosystems Multiplex Sepsis Biomarker Panel Product
Table 60. Atila Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 61. Atila Biosystems Recent Development
Table 62. EDX Medical Company Details
Table 63. EDX Medical Business Overview
Table 64. EDX Medical Multiplex Sepsis Biomarker Panel Product
Table 65. EDX Medical Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 66. EDX Medical Recent Development
Table 67. Seegene Inc Company Details
Table 68. Seegene Inc Business Overview
Table 69. Seegene Inc Multiplex Sepsis Biomarker Panel Product
Table 70. Seegene Inc Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 71. Seegene Inc Recent Development
Table 72. BIOMÉRIEUX Company Details
Table 73. BIOMÉRIEUX Business Overview
Table 74. BIOMÉRIEUX Multiplex Sepsis Biomarker Panel Product
Table 75. BIOMÉRIEUX Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 76. BIOMÉRIEUX Recent Development
Table 77. GCC Biotech INDIA Company Details
Table 78. GCC Biotech INDIA Business Overview
Table 79. GCC Biotech INDIA Multiplex Sepsis Biomarker Panel Product
Table 80. GCC Biotech INDIA Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 81. GCC Biotech INDIA Recent Development
Table 82. Labmix24 Company Details
Table 83. Labmix24 Business Overview
Table 84. Labmix24 Multiplex Sepsis Biomarker Panel Product
Table 85. Labmix24 Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 86. Labmix24 Recent Development
Table 87. Assay Genie Ltd Company Details
Table 88. Assay Genie Ltd Business Overview
Table 89. Assay Genie Ltd Multiplex Sepsis Biomarker Panel Product
Table 90. Assay Genie Ltd Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 91. Assay Genie Ltd Recent Development
Table 92. T2 Biosystems Company Details
Table 93. T2 Biosystems Business Overview
Table 94. T2 Biosystems Multiplex Sepsis Biomarker Panel Product
Table 95. T2 Biosystems Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 96. T2 Biosystems Recent Development
Table 97. Immunexpress Company Details
Table 98. Immunexpress Business Overview
Table 99. Immunexpress Multiplex Sepsis Biomarker Panel Product
Table 100. Immunexpress Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 101. Immunexpress Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Multiplex Sepsis Biomarker Panel Product
Table 105. Merck Revenue in Multiplex Sepsis Biomarker Panel Business (2020-2025) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
Table 110. Authors List of This Report
List of Figures
Figure 1. Multiplex Sepsis Biomarker Panel Picture
Figure 2. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Multiplex Sepsis Biomarker Panel Market Share by Type: 2024 VS 2031
Figure 4. Multiplex Immunoassay Features
Figure 5. Microfluidics-Based Panels Features
Figure 6. Multiplex Molecular Panels Features
Figure 7. Other Features
Figure 8. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Diagnostic Fields (2020-2031) & (US$ Million)
Figure 9. Sepsis Diagnosis Features
Figure 10. Sepsis Prognosis Features
Figure 11. Other Features
Figure 12. Global Multiplex Sepsis Biomarker Panel Market Size Comparison by Clinical Application Scenarios (2020-2031) & (US$ Million)
Figure 13. ED Rapid Triage Features
Figure 14. ICU Monitoring Features
Figure 15. Antimicrobial Stewardship Features
Figure 16. Other Features
Figure 17. Global Multiplex Sepsis Biomarker Panel Market Size by Application (2020-2031) & (US$ Million)
Figure 18. Global Multiplex Sepsis Biomarker Panel Market Share by Application: 2024 VS 2031
Figure 19. Hospital Case Studies
Figure 20. Clinic Case Studies
Figure 21. Other Case Studies
Figure 22. Multiplex Sepsis Biomarker Panel Report Years Considered
Figure 23. Global Multiplex Sepsis Biomarker Panel Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 24. Global Multiplex Sepsis Biomarker Panel Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 25. Global Multiplex Sepsis Biomarker Panel Market Share by Region: 2024 VS 2031
Figure 26. Global Multiplex Sepsis Biomarker Panel Market Share by Players in 2024
Figure 27. Global Multiplex Sepsis Biomarker Panel Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by Multiplex Sepsis Biomarker Panel Revenue in 2024
Figure 29. North America Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. North America Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 31. United States Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Canada Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 35. Germany Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. France Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. U.K. Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Italy Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Russia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Ireland Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Multiplex Sepsis Biomarker Panel Market Share by Region (2020-2031)
Figure 43. China Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Japan Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. South Korea Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. India Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Australia & New Zealand Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 51. Mexico Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Brazil Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Multiplex Sepsis Biomarker Panel Market Share by Country (2020-2031)
Figure 55. Israel Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. UAE Multiplex Sepsis Biomarker Panel Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. Atila Biosystems Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 59. EDX Medical Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 60. Seegene Inc Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 61. BIOMÉRIEUX Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 62. GCC Biotech INDIA Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 63. Labmix24 Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 64. Assay Genie Ltd Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 65. T2 Biosystems Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 66. Immunexpress Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 67. Merck Revenue Growth Rate in Multiplex Sepsis Biomarker Panel Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232